Targeting CCL2/CCR2 signaling overcomes MEK inhibitor resistance in Acute Myeloid Leukemia.
Modak RV, de Oliveira Rebola KG, McClatchy J, Mohammadhosseini M, Damnernsawad A, Kurtz SE, Eide CA, Wu G, Laderas T, Nechiporuk T, Gritsenko MA, Hansen JR, Hutchinson C, Gosline SJC, Piehowski P, Bottomly D, Short N, Rodland K, McWeeney SK, Tyner JW, Agarwal A.
Modak RV, et al. Among authors: mohammadhosseini m.
Clin Cancer Res. 2024 Mar 7. doi: 10.1158/1078-0432.CCR-23-2654. Online ahead of print.
Clin Cancer Res. 2024.
PMID: 38451486